Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Neoplasm progression (Page 6)

510 drugs have been associated with Neoplasm progression in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
RADIUM RA-223 DICHLORIDE 19 5 3 0
RUXOLITINIB 19 4 4 1
SELINEXOR 19 1 4 0
TRABECTEDIN 19 9 5 3
CHLORPHENIRAMINE 18 0 17 0
DOLUTEGRAVIR 18 8 7 0
ETANERCEPT 18 7 4 4
GIMERACIL\OTERACIL\TEGAFUR 18 8 5 2
IVOSIDENIB 18 2 2 0
OLARATUMAB 18 4 0 10
SECUKINUMAB 18 4 14 3
TREMELIMUMAB 18 17 12 0
VINORELBINE\VINORELBINE 18 1 0 0
ADAGRASIB 17 6 9 2
ANAKINRA 17 17 0 0
ASCORBIC ACID 17 3 3 2
BISOPROLOL 17 5 4 0
MIDOSTAURIN 17 7 2 1
ROMIPLOSTIM 17 2 0 0
CABAZITAXEL 16 4 5 2
CEFADROXIL 16 0 0 0
CLOFARABINE 16 10 5 0
DICLOFENAC 16 3 3 2
HYDROXYUREA 16 7 2 0
LOSARTAN 16 2 8 2
PIXANTRONE 16 1 3 1
XELODA 16 2 1 0
AMOXICILLIN\CLAVULANATE 15 2 3 1
APREPITANT 15 3 10 2
CLADRIBINE 15 6 2 1
CYCLOPHOSPHAMIDE\CYTARABINE\DEXAMETHASONE\DOXORUBICIN\METHOTREXATE\VINCRISTINE 15 0 2 0
ENFORTUMAB VEDOTIN-EJFV 15 1 5 0
ESOMEPRAZOLE 15 3 5 1
HYALURONIDASE \RITUXIMAB 15 2 12 2
IBANDRONATE 15 0 0 0
MESNA 15 3 6 0
PROPRANOLOL 15 0 15 0
PYRIDOSTIGMINE 15 13 2 0
SACITUZUMAB GOVITECAN 15 6 6 0
VINDESINE 15 13 1 0
ATENOLOL 14 1 9 1
DANAZOL 14 0 0 0
DESOXIMETASONE 14 2 14 2
HUMAN RHO IMMUNE GLOBULIN 14 0 0 0
MOBOCERTINIB 14 14 2 0
RITUXIMAB-PVVR 14 1 5 0
SACITUZUMAB GOVITECAN-HZIY 14 3 4 0
TADALAFIL 14 4 4 0
THYMOCYTE IMMUNE GLOBULIN NOS 14 12 1 0
BELANTAMAB MAFODOTIN 13 1 1 1
« 1 … 3 4 5 6 7 8 9 … 11 »